Ziel Vergleich von Messgenauigkeit und Interobserver-Variabilität in der computertomografischen Beurteilung von hepatozellulären Karzinomen (HCC) und Lebermetastasen vor und nach transarteriellen selektiven Therapien.
Introduction
Liver metastases and advanced primary liver tumors, such as hepatocellular carcinomas (HCCs), are associated with a poor prognosis. Surgical therapeutic options entail tumor or metastasis resection or liver transplantation (in non-metastasized HCCs). Local non-surgical therapies, such as transarterial chemoembolization (TACE), selective internal radiation therapy (SIRT) and radiofrequency ablation (RFA), can be used in hepatic metastases and HCCs [1 -4] . Systemic therapy could constitute classic cytotoxic chemotherapy or targeted treatment (e. g., sorafenib).
Therapy-induced changes in HCCs and hepatic metastases are classically determined using the firmly established Response Evaluation Criteria in Solid Tumors (RECIST 1.1) [5] or the criteria of the World Health Organization (WHO) [6] . These are based on uni-and bidimensional measurements of the entire lesion which are usually assessed by analyzing transversely oriented images acquired with computed tomography (CT) or magnetic resonance imaging (MRI). However, the mere quantification of the size of a lesion has significant limitations, since treatment such as TACE or SIRT initially results in modified tumor vascularization and not in a size reduction at the initial stage of tumor response [4, 7, 8] . Therefore, the therapeutic effect could be either undetected or underestimated and lead to inappropriate therapeutic decisions (e. g., unnecessary modification of the therapeutic regime).
These limitations led to the development of criteria that also account for vascularization and the extent of possible necrosis. The response criteria according to the European Association of the Study of the Liver (EASL) are based on bidimensional measurements of the vital parts of the tumor, i. e., those revealing arterial contrast uptake [9] . The RECIST guidelines were also adapted to include and quantify tumor necrosis. These criteria are known as modified RECIST (mRECIST) and are still based on unidimensional measurements [10] . Both guidelines primarily aimed to assess HCCs but have already been used in the evaluation of metastases in the context of TACE, SIRT or targeted systemic treatments.
In the clinical routine, radiological assessment of tumor size is usually performed manually. A major disadvantage of manual measurement is the high intraobserver and interobserver variability, which may lead to misinterpretation of tumor response [11] . Previous studies have shown that the use of semi-automatic measuring techniques could reduce this variability [12] , leading to increased precision [13] and thus to a more accurate classification of therapeutic response.
The aim of this study was to determine the measurement precision of established and vitality-based response criteria depending on the method (manual versus semi-automatic) used to measure hepatic metastases and HCCs under endovascular therapy. The inclusion criteria were: (a) transarterial chemoembolization (TACE, n = 29 [40 %]) or (b) selective internal radiation therapy (SIRT, n = 43 [60 %]) of at least one of the liver lesions. Patients who received LIPIODOL ® (Guerbet LLC, Bloomington, Indiana, USA) as part of the TACE regimen were excluded due to its high attenuation and interference with the evaluation of contrast enhancement. TACE was conducted by injection of doxorubicinloaded (50 mg) polyvinyl alcohol particles (100 μm) into the tumor-feeding segmental liver artery. During SIRT loaded spheres (30 -40 μm) with activities between 0.7 and 1.8 GBq were applied.
Materials and Methods
All patients underwent contrast-enhanced multislice CT (MSCT) before and after local ablative therapy. Depending on the survival time, the number of procedures (some patients underwent two or more TACE and/or SIRT) and follow-up CT scans varied. A maximum of two lesions were included per patient to avoid bias due to a great number of genetically and presumably phenotypically similar lesions. In the case of more than two lesions, the two largest ones were chosen.
Written informed consent was obtained from every patient. The study was approved by the local ethics committee and conducted in accordance with the guidelines of the institutional review board.
Data acquisition
Images were taken with a 64-slice dual-source CT scanner (SOMA-TOM ® Definition, Siemens AG, Medical Solutions, Forchheim, Germany). The tube voltage was 120 kV and the collimation was 32 × 0.6 mm. Dose modulation (CARE Dose4 D™, Siemens AG, Medical Solutions, Forchheim, Germany) was undertaken to reduce radiation exposure. Iodine-containing contrast agent (Ultravist ® -370, Bayer Schering Pharma, Leverkusen, Germany) was injected intravenously at a constant flow rate of 5 mL/s. The arterial contrast phase was determined dynamically by means of bolus tracking. The venous contrast phase was defined by a fixed delay of 75 seconds after i. v. injection. All CT data sets were reconstructed at a slice thickness of 1.5 mm, using a reconstruction interval of 0.6 mm.
Data preparation
The CT examinations were transferred to a commercially available, dedicated oncological software suite (mint Lesion TM , Mint Medical GmbH, Heidelberg, Germany), working on a server-client principle. The client, as shown in figure 1 , was installed as additional software on dedicated RIS-PACS workstations. A radiologist (15 years of oncological imaging experience), who was not involved in further measurements or data processing, identified and tagged the malignant liver lesions treated with TACE and SIRT on the basis of the images obtained from the intervention and CT examinations. These liver lesions were identified and measured independently by two readers (R1 with 4 years and R2 with 1 year of oncological imaging experience) who were not involved in data preparation. The evaluation was performed in a semi-random order with a time period of at least 1 month be-tween manual and semi-automatic evaluation of the same lesion. Both readers were blinded with respect to the patients' diseases (i. e., type of liver lesion) and treatments. The abovementioned software, which supports both manual and semi-automatic radiological measurements, was used for evaluation purposes.
Manual evaluation
The assessment comprised measurement of the long axis diameter (LAD, [mm]) of the entire lesion as well as determination of the modified long axis diameter (mLAD, [mm]), defined as the arterial contrast-enhancing portion and presumably representing the vital part of the tumor. Both diameters were measured in transversely oriented CT images, illustrating the largest dimension of the lesion.
Perpendicular to the LAD and mLAD, the shortest diameter of the lesion was determined and referred to as the short axis diameter (SAD, [mm]) and modified short axis diameter (mSAD, [mm]), respectively.
Based on these diameters, the areas were calculated by multiplication, resulting in the WHO (LAD × SAD [mm²]) and the EASL (mLAD × mSAD [mm²]) areas.
Although it is possible to determine the volume manually, this is not feasible in the daily routine and therefore was not performed.
Semi-automatic evaluation
Semi-automatic two-dimensional (area-based) and three-dimensional (volume-based) segmentation was performed on all tagged lesions.
The area-based segmentation process was initiated by drawing a circle around the rough margins of the lesion, preferably in transverse reconstructions. The correct contour was then approximated based on threshold-and contour-based algorithms (▶ Fig. 1 ). Correction tools could be used without restraint to modify any insufficient segmentation results within a maximum time of 120 seconds per measurement. The area-based LAD, SAD, WHO, mLAD, mSAD and EASL were computed from these segmentations.
For volume-based segmentation, additional contours had to be defined from adjacent transverse slices or any perpendicular reconstruction planes [14] . The volume-based LAD, SAD and WHO were derived from the result. Volume-based EASL analysis is not supported by the software and therefore was not performed.
All measurement results from every time point were transferred to a dedicated spreadsheet for further statistical analysis.
Data management
To ensure the comparability of the different parameters, the measurements had to be converted into standard units as described by James et al. [15] . Therefore, all volume and bidimensional measurements were converted into separate diameters as previously published by different groups [16 -18] . These effective diameters were measured in mm and defined as "volume-equivalent and area-equivalent diameters." The volume-equivalent diameter (D vol ) was calculated by inverting the sphere volume for-mula: D vol = (6 × V/π) ⅓ , whereby V = volume measurement (mm 3 ) and D vol = diameter (mm). To convert bidimensional measurements into unidimensional measurements, the surface area of a sphere was assumed. By inverting the area formula A = (π × D s 2 )/ 4, whereby A = bidimensional measurement (mm 2 ) and D s = diameter (mm), the area-equivalent diameters were calculated using the formula D s = 2√((1/π) × A).
Statistical analysis
Statistical analyses were performed using SAS ® software, version 9.4, for Windows (SAS Institute, Cary, NC, USA) and IBM SPSS ® Statistics 22 for Windows (IBM Corporation, Somers, NY, USA). Inferential statistics were intended to be exploratory rather than confirmatory. P-values were used to generate new hypotheses and represent only a metric measure of evidence against the respective null hypothesis. Thus, neither a global significance level nor local levels were determined, and no adjustment for multipli-city was made. P-values ≤ 0.05 were considered statistically significant. Standard descriptive statistical analyses were performed for the parameters LAD, SAD, bidimensional WHO, mLAD, mSAD, bidimensional EASL (all manual and semi-automatic) and volume. Categorical variables are reported as absolute and relative frequencies. Normally distributed continuous variables are reported as mean ± standard deviation, and non-normally distributed continuous variables as median (10 %, 90 % quantile).
To assess interobserver variability between readers R1 and R2 for each parameter, the relative interobserver difference (RID) was determined as RID = | R1 -R2 |/mean (R1, R2) × 100 %.
To determine absolute agreement between the two readers, intraclass correlation coefficients (ICC, two-way random single measure) were calculated for manual and semi-automatic measurements [19] . The ICCs ranged from 0 to 1, whereby values from 0.61 to 0.80 indicate substantial agreement and values from 0.81 to 1 almost perfect agreement. 
Results

Lesion characteristics
137 lesions (57 HCCs, 80 metastases) were measured both manually and semi-automatically on baseline and follow-up CT scans in 72 patients, resulting in a total of 691 observations. As EASL, mLAD and mSAD are only applicable to lesions with a hypervascularized portion, fewer lesions were measured in line with these vitality-based criteria.
The medians of the measurements resulting from the manual and semi-automatic methods differ only slightly from each other, regardless of the number of dimensions taken into account (▶ Table 1 ). Slightly higher deviations can be found in the modified RECIST and EASL criteria.
Relative interobserver difference (RID)
The RID (▶ Table 2 , ▶ Fig. 2) as a measure of divergence between readers R1 and R2reveals no statistically significant difference in the established parameters (LAD, SAD, WHO), regardless of the measurement technique, i. e., manual LAD 6.0 % and semi-automatic area-based LAD 5.9 %, manual SAD 7.7 % and semi-automatic area-based SAD 6.9 %.
In contrast, the deviation in the vitality-based criteria (mLAD, mSAD and EASL) is lower in the semi-automatic area-based measurements compared to manual measurements, i. e., manual mLAD 12.5 % and semi-automatic area-based mLAD 3.4 %, manual EASL 10.4 % and semi-automatic area-based EASL 1.8 %. Moreover, the number of outliers is drastically reduced using the semiautomated area-based method of measurement (▶ Fig. 1) .
The volume can only be determined semi-automatically and has no manually derived equivalent. Its median deviation of 4.1 % is relatively low compared to the other parameters. A larger RID and more outliers are found in the vitality-based parameters (mLAD, mSAD, EASL) when determined manually; this can be counteracted by using a semi-automatic area-based approach.
▶ Abb. 2 Boxplots der relativen Interobserverdifferenz (RID) zwischen Reader 1 und 2 für jeden manuell und semiautomatisch bestimmten flächen-und volumenabgeleiteten Parameter (Längsachsendurchmesser [LAD], Kurzachsendurchmesser [SAD], WHO, Volumen, modifizierter LAD [mLAD], modifizierter SAD [mSAD], EASL). Eine größere RID und mehr Ausreißer können bei den manuell bestimmten Vitalitäts-assoziierten Parametern (mLAD, mSAD, EASL) gefunden werden; dies kann durch ein semiautomatisches Messverfahren reduziert werden.
▶ Table 2 Relative interobserver difference (RID) between reader 1 and reader 2 for each manual and semi-automatic area-based parameter (long axis diameter [LAD], short axis diameter [SAD], WHO, volume, modified LAD [mLAD], modified SAD [mSAD], EASL). The RID in the established parameters (LAD, SAD, WHO) reveals no statistically noticeable difference, whereas the RID for vitality-based parameters is lower in the case of semi-automatic measurement. 
Intraclass correlation coefficient (ICC)
The ICCas an indicator of interobserver agreementis consistently high for the established parameters LAD, SAD and WHO, with no relevant difference between manual and semi-automatic area-based measurements (▶ Table 3 ). The ICCs from manual measurement of mLAD, mSAD and EASL are lower. The manual parameter with the best correlation, mLAD, has an ICC of 0.897, for example.
Taking the type of lesion -HCCs versus metastasesinto account (▶ Table 4 ), there are only small differences regarding the LAD (all ICCs above 0.95). A lower ICC can be found in the SAD of HCCs, especially in the semi-automatic 3 D measurements (3 D SAD 0.780).
Discussion
Manual radiological measurements in CT examinations are an established clinical approach and form the basis for any evaluation of imaging in oncology. Nevertheless, numerous recent studies have demonstrated lower interobserver variability and higher reproducibility with semi-automatic measurements [12, 13, 17, 20 -24] . These advantages permit more reliable and accurate classification of the therapeutic response and directly influence treatment decisions. These studies are limited in that they mostly focused on the relatively easy task of lung nodule [17, 22, 23] or lymph node segmentation in CT examinations [12, 13] .
The segmentation of liver lesions in MRI examinations is also firmly established and usually involves a semi-automatic, volume-based approach [25, 26] . On the other hand, reliable segmentation of liver lesions in CTwith its lower soft-tissue-con-trastis a more demanding task and has been addressed only recently [24, 27] . Special challenges are posed by the initially variable morphology which changes over the course of new targeted und endovascular therapies due to decreased tumor vascularization with subsequently reduced contrast enhancement or even necrosis. In light of these unavoidable hindrances, the mode of measurement (manual or semi-automatic) should not add any further uncertainty.
Our data reveal a consistently high level of measurement precision (reflected by the ICC) for any semi-automatically derived measurements, including the vitality-based parameters mLAD, mSAD and EASL. In contrast, the precision of the manual measurements of these vitality-based parameters is considerably lower. As the ICC does not mainly depend on the number of cases, this could be explained at least in part by the smaller area to be measured with a consecutively higher variation.
One possible explanation for the higher ICCs of the semi-automatically derived measurements is that the standardized semi-automatic workflow offers guidance (e. g. by proposing reconstruction planes or boundaries) in difficult situations, counteracting the lesion-and therapy-dependent variations and leading to less variation.
This advantage is not expected to come to the fore in the relatively easy task of generally determining lesion size. Our data ultimately reveal no relevant differences in precision between manual and semi-automatic measurements for the established parameters LAD, SAD and WHO, regardless of the lesion type (HCCs versus metastases).
In this regard our results are consistent with previous studies that report a higher ICC for semi-automatic CT measurements of lymph nodes [13] and pulmonary nodules [22, 23] and extend the ▶ Table 3 Intraclass correlation coefficients (ICC) (two-way random single measure) and 95 % confidence intervals for agreement between reader 1 and 2 in manual and semi-automatic measurements (long axis diameter [LAD], short axis diameter [SAD], WHO, volume, modified LAD [mLAD], modified SAD [mSAD], EASL). Semi-automatic, area-based determination of vitality-based parameters (mLAD, mSAD, EASL) leads to substantially higher agreement (ICC) between reader 1 and 2 compared to manual measurements of the same parameters. applicability to the semi-automatic evaluation of liver lesions in CT. Analogous results were published recently with a focus on MRI evaluation of liver lesions after intra-arterial therapy [28, 29] . For the probably more demanding CT segmentation and measurement, a current publication evaluated HCCs under systemic molecular-targeted therapy [30] . In contrast to this study, we applied therapy (TACE or SIRT) selectively to the liver arteries that could make a difference in the homogeneity and intensity of the therapy effects, making measurements even more difficult.
As an additional benefit, a semi-automatic workflow facilitates standardized and complete documentation [31] . This helps reduce measurement time in follow-up examinations by a third, compensating for the slightly longer, initial segmentation time [32] . Furthermore, it offers a systematic overview and guidance in patients with multiple examinations, possibly at different sites, thereby permitting monitoring of a diversified therapeutic spectrum.
Limitations
This study is limited to the extent that the measured liver lesions were not excised. Thus, the actual size and, depending on this, the accuracy could not be determined. However, a surgical intervention would not have been justified, and the precisionas a relative measureis not influenced by our approach, which is accepted for in-vivo studies [17] .
Furthermore, we chose a single-center, retrospective study design. Because the focus of interest was the measurement agreement between the readers, each measurement was regarded as independent, thus potentially disregarding correlations between lesions in the same patient and between different time points.
We did not evaluate the mean segmentation time which could pose a bias due to over-accurate editing of contours. To prevent this we restricted the maximum segmentation time to 120 seconds per lesion [24] .
The CT scanner and reconstruction protocols were kept constant to the disadvantage of limited generalizability.
Conclusion
We conclude that vitality-based tumor measurements of hepatocellular carcinomas and metastases after transarterial local therapies should be performed semi-automatically due to greater measurement precision, thus increasing the reproducibility and, in turn, the reliability of therapeutic decisions. Manual and semiautomatic measurements of established parameters offer the same level of precision, but preference should be given to the semi-automatic approach due to the possibility of generating systematic documentation.
▶ Table 4 Intraclass correlation coefficients (ICC) by tumor entity (two-way random single measure) and 95 % confidence limits for agreement between reader 1 and 2 in manual and semi-automatic measurements (long axis diameter [LAD], short axis diameter [SAD], WHO, volume, modified LAD [mLAD], modified SAD [mSAD], EASL). The mLAD, mSAD and bidimensional EASL were not applicable to metastases and have therefore been omitted. The ICC is equally high for LAD regardless of the measurement method. 
